Skip to main content

RxSight, Inc.

For the period ended Sep 30, 2025. Filed Nov 5, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 5, 2025

RXST$4.86+7.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(In thousands, except share and per share amounts)

September 30,December 31,
20252024
(Unaudited)
Assets
Current assets:
Cash and cash equivalents$29,633$16,706
Short-term investments197,883220,517
Accounts receivable, net24,15130,050
Inventories, net28,95022,009
Prepaid and other current assets3,2604,541
Total current assets283,877293,823
Property and equipment, net13,09612,413
Operating leases right-of-use assets10,27611,217
Restricted cash748750
Other assets536360
Total assets$308,533$318,563
Liabilities and stockholders' equity
Current liabilities:
Accounts payable$3,377$4,544
Accrued expenses and other current liabilities17,62120,358
Lease liabilities1,293974
Total current liabilities22,29125,876
Long-term lease liabilities10,27211,322
Other long-term liabilities—127
Total liabilities32,56337,325
Commitments and contingencies (Note 8)
Stockholders' equity:
Common stock, $0.001 par value, 900,000,000 shares authorized, 41,081,550 shares issued and outstanding as of September 30, 2025 and 40,428,220 shares issued and outstanding as of December 31, 20244140
Preferred stock, $0.001 par value, 100,000,000 shares authorized, no shares issued and outstanding——
Additional paid-in capital927,756903,127
Accumulated other comprehensive income60166
Accumulated deficit(651,887)(622,095)
Total stockholders' equity275,970281,238
Total liabilities and stockholders' equity$308,533$318,563
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.